Matches in Wikidata for { <http://www.wikidata.org/entity/Q64710650> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- Q64710650 description "clinical trial" @default.
- Q64710650 description "ensayu clínicu" @default.
- Q64710650 description "klinisch onderzoek" @default.
- Q64710650 description "клінічне випробування" @default.
- Q64710650 name "Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia" @default.
- Q64710650 type Item @default.
- Q64710650 label "Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia" @default.
- Q64710650 prefLabel "Efficacy and Safety of Midostaurin in Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia" @default.
- Q64710650 P1050 Q64710650-889EFAB8-2E9A-499F-802C-CB0C18D976EE @default.
- Q64710650 P1050 Q64710650-A2321B4E-A398-4F00-AA78-3BB7C0FED847 @default.
- Q64710650 P1132 Q64710650-1E090E7D-7782-4709-A0C6-27D80201E95C @default.
- Q64710650 P1476 Q64710650-16B7483B-7C6C-4AD3-9CBC-A63CD279C0F8 @default.
- Q64710650 P17 Q64710650-0A860443-D2AD-432A-962B-AAEBF3DA41D5 @default.
- Q64710650 P17 Q64710650-1D3DD99C-7440-4849-824F-4B3CC33FC8A7 @default.
- Q64710650 P17 Q64710650-27EDCCA1-0391-42F5-AAF8-7C6909DDC97F @default.
- Q64710650 P17 Q64710650-4427E618-EA0A-44D9-BF83-2F053179E575 @default.
- Q64710650 P17 Q64710650-49ACB22F-D159-481B-9297-695485C8895B @default.
- Q64710650 P17 Q64710650-5C83C31D-7A6C-44DA-ABB1-D88B1D238A6A @default.
- Q64710650 P17 Q64710650-5E145F39-D82D-4BBF-8111-D4663B58A082 @default.
- Q64710650 P17 Q64710650-647228E3-4F25-473A-964E-BDC1D07ABF96 @default.
- Q64710650 P17 Q64710650-B46265C4-4576-487E-81A0-1BB61590B2E7 @default.
- Q64710650 P17 Q64710650-EC2348C9-098D-49BD-9412-02F16F284F90 @default.
- Q64710650 P17 Q64710650-EDCA2048-5886-477B-9162-699B8C6AB9F5 @default.
- Q64710650 P17 Q64710650-F41A2BFD-2119-48E5-A5A4-151DE0274F4B @default.
- Q64710650 P2899 Q64710650-1BF1E6B2-EF18-4160-927A-09CBA60D0713 @default.
- Q64710650 P3098 Q64710650-E762CED0-E447-4AA0-9E9B-FF0091107CC3 @default.
- Q64710650 P31 Q64710650-3F949CB3-F077-43DC-96BC-4E7B4125A1E1 @default.
- Q64710650 P580 Q64710650-FECB1A44-4A2A-48CD-A667-4E27F9F39668 @default.
- Q64710650 P582 Q64710650-EC0E6D06-202E-4FEB-8B5E-E155DF083BBE @default.
- Q64710650 P6099 Q64710650-1752100B-4090-46D4-A2ED-8257D5794730 @default.
- Q64710650 P6153 Q64710650-8D9B7541-A021-46BD-9E07-AB6F412A6E77 @default.
- Q64710650 P6153 Q64710650-984FAC56-6CA2-47FF-BD23-6DB02AAB2EC5 @default.
- Q64710650 P8363 Q64710650-568500E0-6F2D-4079-BEA2-22D75DDD7D32 @default.
- Q64710650 P859 Q64710650-F301565C-DAE6-4394-9AEF-06F6D26744CC @default.
- Q64710650 P921 Q64710650-D1CFBCC5-387C-4311-8BED-6366DDD0EA65 @default.
- Q64710650 P1050 Q112670 @default.
- Q64710650 P1050 Q29496 @default.
- Q64710650 P1132 "+116" @default.
- Q64710650 P1476 "A Single Arm, Phase II, Open-Label Study to Determine the Efficacy of 100mg Twice Daily Oral Dosing of Midostaurin Administered to Patients With Aggressive Systemic Mastocytosis or Mast Cell Leukemia +/- an Associated Hematological Clonal Non-Mast Cell Lineage Disease" @default.
- Q64710650 P17 Q142 @default.
- Q64710650 P17 Q145 @default.
- Q64710650 P17 Q16 @default.
- Q64710650 P17 Q183 @default.
- Q64710650 P17 Q20 @default.
- Q64710650 P17 Q30 @default.
- Q64710650 P17 Q31 @default.
- Q64710650 P17 Q36 @default.
- Q64710650 P17 Q40 @default.
- Q64710650 P17 Q408 @default.
- Q64710650 P17 Q43 @default.
- Q64710650 P17 Q55 @default.
- Q64710650 P2899 "+18" @default.
- Q64710650 P3098 "NCT00782067" @default.
- Q64710650 P31 Q30612 @default.
- Q64710650 P580 "2008-10-13T00:00:00Z" @default.
- Q64710650 P582 "2014-12-01T00:00:00Z" @default.
- Q64710650 P6099 Q42824440 @default.
- Q64710650 P6153 Q49117 @default.
- Q64710650 P6153 Q507154 @default.
- Q64710650 P8363 Q78089383 @default.
- Q64710650 P859 Q507154 @default.
- Q64710650 P921 Q19000398 @default.